Skip to content

Melissa B Epperly, Director at Roivant Sciences, sold ROIV on Oct 1, 2026

Data as of Oct 16

▼ SELL$608K16,850 shares at $36.08Melissa B Epperly DirectorROIV Roivant Sciences Ltd.
Watch ROIV
Traded
Oct 1, 2026
Disclosed
Oct 5, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Melissa B Epperly, Director at Roivant Sciences, sold ROIV on Oct 1, 2026TRADEDDISCLOSED
ROIVSimilar stocks (XLV — its sector index fund), rebased to ROIV's price on the disclosure day
ROIV since disclosure
−6.3%
after the sale
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund

Change in closing price from Oct 5, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLMelissa B Epperly DirectorROIV Roivant Sciences Ltd.$32.9Kdisclosed Oct 5 · filed 4 days after the trade

See every trade on ROIV →